[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@MarkC_LVB Mark C
Mark C posts on X about $arwr, $alny, target, $prqr the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX -XX%
- X Month XXXXXX +3,533%
- X Months XXXXXX +670%
- X Year XXXXXXX +256%
Mentions: X #
Followers: XXX #
- X Week XXX +1.10%
- X Month XXX +1.70%
- X Months XXX +4.20%
- X Year XXX +6.80%
CreatorRank: undefined #
Social Influence
Social category influence stocks XXXX%
Social topic influence $arwr #29, $alny 25%, target 12.5%, $prqr 12.5%, $nvo 12.5%, $lly 12.5%, $drna XXXX%
Top accounts mentioned or mentioned by @artsstocks @sonichedgefund @rnaianalyst @jmaraganore @arrowheadpharma @ionisdisrupts @cramertracker @occamstooth @elikorey @paulmarganski
Top assets mentioned Arrowhead Research Corporation (ARWR) Alnylam Pharmaceuticals, Inc. (ALNY) Novo-Nordisk (NVO) Eli Lilly and Company (LLY)
Top Social Posts
Top posts by engagements in the last XX hours
"This is how its done @JMaraganore was a pioneer in RNAi while $ARWR is main competitor for $ALNY still willing to recognize excellence and celebrate success for patients"
X Link 2025-11-18T17:33Z XXX followers, 5499 engagements
"What could be the next big Tech Whats more technology focused than the ability to program the human body to fight disease $ARWR can potentially target all significant disease processes and silence them. $ALNY $PRQR"
X Link 2025-11-26T17:22Z XXX followers, 1096 engagements
"@EliKorey While I still dont think BP can pay enough to satisfy $ARWR youd have to think $LLY is watching closely. As one of the few BP with the $$ and also major risk should INHBE succeed. In addition $NVO has RNAi assets from $DRNA while LLY does not"
X Link 2025-12-08T16:40Z XXX followers, XXX engagements